Nina Maouelainin, DO, MBA, FCCP
@drninalung.bsky.social
1K followers
240 following
2 posts
Interventional Pulmonologist| Entrepreneur | CEO, Lung Health Services | Building turnkey IP programs|Mentor Educator and innovator.
#WiIPstrong #PulmSky #MedSky #HearHer #WomenInMedicine #WhiteRibbonProject #younglungcancer #Innovation #WomenInmedicine
Posts
Media
Videos
Starter Packs
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
CHEST is seeking the next Editor in Chief of #CHESTAdvocates —our quarterly digital publication amplifying the voice of advocacy.
✅ 3-year term
✅ Stipend included
✅ Lead conversations on policy, regulation, and equity in care
📅 Apply by October 31: info.chestnet.org/chest-advoca...
#HealthAdvocacy
✅ 3-year term
✅ Stipend included
✅ Lead conversations on policy, regulation, and equity in care
📅 Apply by October 31: info.chestnet.org/chest-advoca...
#HealthAdvocacy
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
OncLive
@onclive.bsky.social
· May 31
Amivantamab Plus Chemo Maintains PFS Benefit in EGFR+ NSCLC Regardless of Osimertinib Resistance Mechanism
Amivantamab/chemotherapy demonstrated sustained efficacy, despite the osimertinib resistance mechanism in patients with EGFR-mutated NSCLC.
www.onclive.com
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP
Reposted by Nina Maouelainin, DO, MBA, FCCP